Bayesian methods for evidence synthesis in cost-effectiveness analysis.
about
Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutationsSystematic review and network meta-analysis of interventions for fibromyalgia: a protocolMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysisMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysisSystematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancerAn overview of conducting systematic reviews with network meta-analysisComparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysisSystematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancerTreatments for shoulder impingement syndrome: a PRISMA systematic review and network meta-analysisThe relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisMinisternotomy or minithoracotomy for minimally invasive aortic valve replacement: a Bayesian network meta-analysisEfficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-AnalysisIncorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methodsThe use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients.Incorporating data from various trial designs into a mixed treatment comparison model.Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis.Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data.Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain.'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials.Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial.The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysmsCost-effectiveness of interventions for increasing the possession of functioning smoke alarms in households with pre-school children: a modelling study.Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships.Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model.Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis.Network meta-analysis of survival data with fractional polynomials.Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials.Efficacy of new generation antidepressants: differences seem illusoryGastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysisMultiple treatment comparison meta-analyses: a step forward into complexity.Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation.Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis.Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in EuropeSystematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis
P2860
Q21132357-EDEB064F-602B-4B18-83EA-B7A59F394E4BQ21195844-95F077B6-BBB2-4C97-97BA-8D4D4E405E8EQ24202055-4601D603-E649-4A3E-A446-CAB0B613BE43Q26751187-22DD3753-009E-471F-B1E9-F619BEF4BCEAQ26768128-CD765BCA-0C68-4651-A9E4-35ED062AFA59Q26798301-00E1C0F0-CB4D-427D-A2EA-B3DDA0A2CA3DQ26827222-8513CBA5-48E7-445D-B65A-B0BC2C29F1ACQ26828622-317077F2-6B1C-4E1C-92E5-FA9EB5C8CDADQ26864932-A59CB9B7-0821-4DAC-BDD3-7C55D1B828A7Q27011699-36AFF934-BF4B-48C5-8E76-380208E0FBFBQ27690869-DB1487B1-805A-45F1-81B6-645A35E26CF6Q28087211-829C292F-53AB-48A5-A1DD-9BA2A318660AQ28087732-9B2B77E9-8029-4555-8934-2187D796B38EQ28547354-96B7A167-4AB1-4ACF-B5DB-41C3439A23C1Q30580634-2734ADDD-66A4-4807-BDE7-0075BCDF7BFBQ30586377-33259D23-00DB-49F7-AA21-E61611BDFD56Q30594247-1EB44BB6-EDCF-4CDD-8DEC-D9C5330EB6E5Q30843177-F927823E-78B6-4A69-BF8B-52967CD5196EQ30850451-A59748CF-A7F5-40B7-9166-58347B4C07A3Q31135481-0ED05EB0-DE04-4E1A-AECA-1396DF4E9818Q33261643-0789BB66-3627-4206-9CD1-45EBCD3995A5Q33493047-371F0E9D-B210-48E0-A1BB-EC4BC8ED62D7Q33576871-EBA6EE66-04A4-42DB-9E6C-A330445258C7Q33600403-B3AA9954-7919-41D6-9356-14824F0F4BD8Q33629488-47BE8307-7275-4A48-BF5A-9A21A45F1993Q33716902-39525A1E-4F2E-4357-86AF-D160491B404EQ33735269-7AC8F497-499F-4CCE-AFD6-3A45BA05F8AEQ33766133-4731F1AA-9CA8-4CB5-A420-4C4C789C2366Q33812681-8B26C3AC-5BDE-40F3-9D56-44312B800055Q33891529-C3BD5EE8-6DB5-4EB4-83E0-ADAA79DB9B69Q34573490-37F66B4F-79B6-4F6F-A5D5-F8906EB5742EQ34765596-75F2ABF6-7F73-414B-ABC3-3F08FC67DD7DQ34915090-E9E2950C-AB89-4A70-8DB7-DBB5F7947281Q35009609-455DF557-D8B3-4D17-8939-59811E090DD5Q35089776-14009D1F-D2C3-492F-AF10-3282259CF182Q35103135-B6F8BD0E-5B5E-496D-993D-005903DDD0DCQ35123017-9BCB5F62-30C7-4FC2-861F-AE379E06F344Q35180222-A5ABE81A-47F2-4203-897C-CDF174DC428DQ35180653-05A83E52-24DF-44A8-B598-E36C0688FB0AQ35345620-746C573E-C6D1-4ACE-AFF1-C6BFC99B661E
P2860
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@ast
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@en
type
label
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@ast
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@en
prefLabel
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@ast
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@en
P2093
P2860
P1433
P1476
Bayesian methods for evidence synthesis in cost-effectiveness analysis.
@en
P2093
Alex Sutton
Guobing Lu
Mark Sculpher
Nicky Welton
Nicola Cooper
P2860
P356
10.2165/00019053-200624010-00001
P577
2006-01-01T00:00:00Z
P6179
1042153574